Todd Neale

New York

Senior Medical Journalist and Associate News Editor at TCTMD

Senior Medical Journalist/Associate News Editor for TCTMD

Featured in: Favicon

tctmd.com

go.com

medpagetoday.com Favicon

newsbreak.com Favicon

climatedepot.com Favicon

abcnews.go.com

Articles

Underexpanded Acurate Valves Come With Higher Stroke Risk, Study Confirms

1 week ago | tctmd.com | Todd Neale

Underexpansion of the Acurate neo and neo2 transcatheter heart valves (Boston Scientific) is tied to a greater risk for stroke, a Swiss study affirms.
Greater Frailty Means More Complications, Higher Mortality After PCI

1 week ago | tctmd.com | Todd Neale

Frailty is common among older patients undergoing PCI in the United States, and the more severe it is, the greater the likelihood of complications and of dying in the hospital, data from the CathPCI registry shows.
Delays in STEMI Treatment Remain Common, Tied to Worse PCI Outcomes

2 weeks ago | tctmd.com | Todd Neale

Despite substantial variability in meeting time-to-treatment targets for STEMI patients across US hospitals, many continue to face delays, which are associated with poorer outcomes, according to an analysis of the American Heart Association Get With The Guidelines Coronary Artery Disease (GWTG-CAD) registry.
CMR May Improve Assessment of ICD Need in Cardiac Sarcoidosis

2 weeks ago | tctmd.com | Todd Neale

The imaging was better than societal recommendations at discriminating long-term risk of ventricular arrhythmias. Cardiovascular magnetic resonance (CMR) imaging may help physicians make decisions about which patients with suspected cardiac sarcoidosis require an implantable cardioverter-defibrillator (ICD) to prevent fatal or life-threatening ventricular arrhythmias, a new analysis suggests.
Low Bleeding Risk With Abelacimab in AF Patients Undergoing Invasive Procedures

2 weeks ago | tctmd.com | Todd Neale

With the factor XI inhibitor, clinicians may have more flexibility when managing anticoagulation in this common scenario. If the novel factor XI inhibitor abelacimab reaches the market for patients with atrial fibrillation (AF) who require anticoagulation, it may not be necessary to interrupt treatment ahead of invasive procedures, at least in cases deemed to carry a low risk for bleeding, an analysis of the AZALEA-TIMI 71 trial suggests.
Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

3 weeks ago | tctmd.com | Todd Neale

Treatment should be stopped if nonarteritic anterior ischemic optic neuropathy, which can cause vision loss, is diagnosed. Nonarteritic anterior ischemic optic neuropathy (NAION), which can lead to vision loss, is a “very rare” side effect of treatment with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide, the safety committee of the European Medicines Agency (EMA) has concluded.
JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

3 weeks ago | tctmd.com | Todd Neale

The aim is to “activate these guidelines in a way that they become more actionable for clinicians,” Harlan Krumholz says. The Journal of the American College of Cardiology has introduced a new approach to promoting practice guidelines, dedicating its entire June 10, 2025, issue to the latest US guidance on ACS management released earlier this year.
Simple, Phone-Based Strategy Improves BP Control in Stroke Survivors

3 weeks ago | tctmd.com | Todd Neale

News Conference News ESOC 2025 The intervention, tested out in Ghana, is unique as it relies on basic mobile phones, not smartphones. HELSINKI, Finland—In Ghana, survivors of a recent stroke who had hypertension experienced significant improvements in blood pressure control with a simple, mobile-health (mHealth) intervention led by nurses, according to the results of the PINGS-2 trial.
High Residual Risk of Recurrent Stroke Seen in AF Patients on Anticoagulants

1 month ago | tctmd.com | Todd Neale

News Conference News ESOC 2025 The findings highlight the need to both ensure adherence to anticoagulation and control other risk factors. HELSINKI, Finland—Patients with atrial fibrillation (AF) who have had an ischemic stroke continue to have a high risk of recurrent stroke even when they’re treated with oral anticoagulation, a systematic review and meta-analysis shows.
Less Intense Checks May Be OK After IV Thrombolysis for Stroke: OPTIMISTmain

1 month ago | tctmd.com | Todd Neale

News Conference News ESOC 2025 Pulling back on the level of monitoring could improve nursing workflows and reduce resource use. HELSINKI, Finland—It may be possible to safely cut back on the level of monitoring performed in select patients with acute ischemic stroke treated with IV thrombolysis, results of the OPTIMISTmain trial suggest.